Informing evidence-based implementation of genomic testing in rare disease and cancer
(A) National recruitment sites, participant demographics, and willingness for data to be used for further research.
(B and C) Diagnostic outcomes of genomic testing across (B) 13 rare disease and (C) 6 cancer studies.